Asante Solutions Inc (PUMP) Downgraded by Zacks Investment Research
Asante Solutions Inc (NASDAQ:PUMP) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a research report issued on Wednesday, July 12th.
According to Zacks, “ProPetro Holding Corp. provides oilfield services. It offers hydraulic fracturing and other complementary services to leading upstream oil and gas companies engaged in the exploration and production of North American unconventional oil and natural gas resources. ProPetro Holding Corp. is headquartered in Midland, Texas. “
Other analysts have also recently issued reports about the company. Evercore ISI reissued a “buy” rating on shares of Asante Solutions in a research note on Sunday, May 14th. Instinet reissued a “buy” rating and set a $19.00 target price on shares of Asante Solutions in a research note on Wednesday, April 19th. Nomura started coverage on Asante Solutions in a research note on Wednesday, April 19th. They set a “buy” rating and a $19.00 target price for the company. Tudor Pickering started coverage on Asante Solutions in a research note on Monday, April 17th. They set a “buy” rating for the company. Finally, Goldman Sachs Group, Inc. (The) assumed coverage on Asante Solutions in a research note on Tuesday, April 11th. They set a “buy” rating for the company. Two investment analysts have rated the stock with a sell rating, one has assigned a hold rating, ten have issued a buy rating and one has issued a strong buy rating to the company. Asante Solutions has a consensus rating of “Buy” and a consensus target price of $19.00.
Shares of Asante Solutions (PUMP) opened at 12.20 on Wednesday. The company’s 50 day moving average is $13.45 and its 200 day moving average is $13.45. Asante Solutions has a 12-month low of $11.68 and a 12-month high of $15.30. The firm’s market capitalization is $1.01 billion.
Asante Solutions (NASDAQ:PUMP) last posted its earnings results on Wednesday, May 10th. The company reported ($0.43) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.05) by $0.38. The company had revenue of $171.90 million during the quarter, compared to analyst estimates of $169.68 million. Asante Solutions’s revenue was up 95.6% compared to the same quarter last year. On average, analysts forecast that Asante Solutions will post $0.31 earnings per share for the current year.
TRADEMARK VIOLATION NOTICE: “Asante Solutions Inc (PUMP) Downgraded by Zacks Investment Research” was originally published by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are accessing this article on another publication, it was stolen and reposted in violation of US and international trademark & copyright laws. The correct version of this article can be viewed at https://www.thecerbatgem.com/2017/08/08/asante-solutions-inc-pump-lowered-to-sell-at-zacks-investment-research-updated-updated-updated.html.
A number of institutional investors have recently added to or reduced their stakes in the company. Strs Ohio purchased a new position in Asante Solutions during the second quarter worth $103,000. Tudor Investment Corp ET AL purchased a new position in Asante Solutions during the first quarter worth $322,000. Nationwide Fund Advisors purchased a new position in Asante Solutions during the first quarter worth $326,000. Teachers Retirement System of The State of Kentucky purchased a new position in Asante Solutions during the first quarter worth $677,000. Finally, Bank of New York Mellon Corp bought a new stake in Asante Solutions during the second quarter valued at approximately $1,383,000.
Asante Solutions Company Profile
Asante Solutions, Inc is a medical device company. The Company is a manufacturer of Asante Snap Insulin Pump System (Snap system), which is a pump featuring a modular design with pre-filled insulin cartridges and disposable pump bodies, utilized in combination with a controller. The Snap system comprises four components: the Snap system controller, a disposable pump body, disposable pre-filled insulin cartridges and disposable infusion sets.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Stock Ratings for Asante Solutions Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Asante Solutions Inc and related stocks with our FREE daily email newsletter.